Surrozen Competitors
| SRZN Stock | USD 21.55 0.00 0.00% |
Surrozen vs VistaGen Therapeutics Correlation
Excellent diversification
The correlation between Surrozen and VTGN is -0.64 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Surrozen and VTGN in the same portfolio, assuming nothing else is changed.
Moving against Surrozen Stock
| 0.85 | ACLX | Arcellx | PairCorr |
| 0.76 | RANI | Rani Therapeutics | PairCorr |
| 0.72 | EVGN | Evogene | PairCorr |
| 0.67 | APLT | Applied Therapeutics | PairCorr |
| 0.67 | CRBP | Corbus Pharmaceuticals | PairCorr |
Surrozen Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Surrozen and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Surrozen and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Surrozen does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Surrozen Stock performing well and Surrozen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Surrozen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CGTX | 3.96 | (0.51) | 0.00 | (0.17) | 0.00 | 8.89 | 24.96 | |||
| TIL | 4.09 | (1.21) | 0.00 | (2.27) | 0.00 | 6.59 | 55.58 | |||
| TVGN | 4.86 | (0.92) | 0.00 | (1.03) | 0.00 | 10.00 | 26.81 | |||
| SEER | 1.46 | (0.21) | 0.00 | 2.68 | 0.00 | 3.41 | 9.98 | |||
| IRD | 3.39 | 0.49 | 0.12 | 0.56 | 3.55 | 7.62 | 26.50 | |||
| ATOS | 3.18 | (0.51) | 0.00 | 2.84 | 0.00 | 6.78 | 20.34 | |||
| GLSI | 6.16 | 2.04 | 0.31 | (8.45) | 5.34 | 19.77 | 36.10 | |||
| AGEN | 3.22 | (0.42) | 0.00 | (0.89) | 0.00 | 6.63 | 30.06 | |||
| IMMX | 4.92 | 0.89 | 0.19 | 0.88 | 4.31 | 15.04 | 28.79 | |||
| VTGN | 5.60 | (1.70) | 0.00 | (1.88) | 0.00 | 7.61 | 96.59 |
Cross Equities Net Income Analysis
Compare Surrozen and related stocks such as Cognition Therapeutics, Instil Bio, and Tevogen Bio Holdings Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CGTX | (7 M) | (7 M) | (7 M) | (7 M) | (7 M) | (7 M) | (7 M) | (7 M) | (7 M) | (7 M) | (10.1 M) | (11.7 M) | 757 K | (25.8 M) | (34 M) | (30.6 M) | (29 M) |
| TIL | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (37.7 M) | (156.8 M) | (223.2 M) | (156.1 M) | (74.1 M) | (66.7 M) | (70.1 M) |
| TVGN | (15.6 M) | (15.6 M) | (15.6 M) | (15.6 M) | (15.6 M) | (15.6 M) | (15.6 M) | (15.6 M) | (15.6 M) | (15.6 M) | (15.6 M) | (15.6 M) | 4.4 M | (60.5 M) | (10.1 M) | (9.1 M) | (9.6 M) |
| SEER | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (16 M) | (32.8 M) | (71.2 M) | (93 M) | (86.3 M) | (86.6 M) | (77.9 M) | (81.8 M) |
| IRD | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (24.6 M) | (56.7 M) | 17.9 M | (10 M) | (57.5 M) | (51.8 M) | (49.2 M) |
| ATOS | (122.9 K) | (3.4 M) | (5.1 M) | (10.8 M) | (14.7 M) | (15.8 M) | (6.4 M) | (8.1 M) | (11.4 M) | (17.2 M) | (17.8 M) | (20.6 M) | (26.2 M) | (30.1 M) | (25.5 M) | (23 M) | (21.8 M) |
| GLSI | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.7 M) | (3.4 M) | (1.9 M) | (4.6 M) | (7.8 M) | (8.9 M) | (15.8 M) | (14.2 M) | (13.5 M) |
| AGEN | (18.1 M) | (23.3 M) | (11.3 M) | (30.1 M) | (42.5 M) | (87.9 M) | (127 M) | (120.7 M) | (159.7 M) | (107.7 M) | (180.9 M) | (23.9 M) | (220.1 M) | (245.8 M) | (227.2 M) | (204.5 M) | (194.3 M) |
| IMMX | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (1.1 M) | (24.4 M) | (8.2 M) | (15.4 M) | (21.6 M) | (19.5 M) | (18.5 M) |
| VTGN | (4.8 K) | (12.2 M) | (12.9 M) | (3 M) | (13.9 M) | (47.2 M) | (10.3 M) | (14.3 M) | (24.6 M) | (20.8 M) | (17.9 M) | (47.8 M) | (59.2 M) | (29.4 M) | (51.4 M) | (46.3 M) | (44 M) |
Surrozen and related stocks such as Cognition Therapeutics, Instil Bio, and Tevogen Bio Holdings Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Surrozen financial statement analysis. It represents the amount of money remaining after all of Surrozen operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Surrozen Competitive Analysis
The better you understand Surrozen competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Surrozen's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Surrozen's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Surrozen Competition Performance Charts
Five steps to successful analysis of Surrozen Competition
Surrozen's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Surrozen in relation to its competition. Surrozen's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Surrozen in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Surrozen's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Surrozen, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Surrozen position
In addition to having Surrozen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Municipals ETFs Thematic Idea Now
Broad Municipals ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Municipals ETFs theme has 56 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Municipals ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Surrozen Correlation with its peers. To learn how to invest in Surrozen Stock, please use our How to Invest in Surrozen guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Will Biotechnology sector continue expanding? Could Surrozen diversify its offerings? Factors like these will boost the valuation of Surrozen. If investors know Surrozen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Surrozen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (17.59) | Revenue Per Share | Quarterly Revenue Growth (0.90) | Return On Assets | Return On Equity |
The market value of Surrozen is measured differently than its book value, which is the value of Surrozen that is recorded on the company's balance sheet. Investors also form their own opinion of Surrozen's value that differs from its market value or its book value, called intrinsic value, which is Surrozen's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Surrozen's market value can be influenced by many factors that don't directly affect Surrozen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surrozen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Surrozen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Surrozen's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.